Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;271(10):6739-6749.
doi: 10.1007/s00415-024-12631-7. Epub 2024 Aug 22.

Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world study

Giordano Cecchetti  1   2   3   4 , Federica Agosta  1   3   4 , Giulia Rugarli  1   3   4 , Edoardo Gioele Spinelli  1   3   4 , Alma Ghirelli  1   3   4 , Matteo Zavarella  1   3   4 , Ilaria Bottale  1   3   4 , Francesca Orlandi  1   3   4 , Roberto Santangelo  1   2 , Francesca Caso  1 , Giuseppe Magnani  1 , Massimo Filippi  5   6   7   8
Affiliations

Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world study

Giordano Cecchetti et al. J Neurol. 2024 Oct.

Abstract

Background and objectives: This study evaluates the discriminative performance of the automated Lumipulse plasma pTau-217 compared to plasma pTau-181 and the Aβ42/Aβ40 ratio across cerebrospinal fluid (CSF) A/T classes and diagnostic groups within a memory-center-based population of cognitively impaired patients.

Methods: This cross-sectional study in a Memory Center enrolled 98 patients along the AD continuum or affected by other neurodegenerative disorders, stratified by CSF A/T status and clinical syndrome. Plasma pTau-217, pTau-181, and Aβ42/Aβ40 were measured using Lumipulse. Relationships with CSF and glomerular filtration rate (GFR) were explored. ROC analysis was conducted to assess diagnostic performance.

Results: The CSF A/T profiles included 49 A+/T+, 8 A+/T-, and 41 A-/T-. Clinical diagnoses at discharge were AD-dementia (AD-DEM), AD-MCI, NonAD-MCI, and NonAD-dementia (NonAD-DEM). Plasma pTau-217 and the pTau-217/Aβ42 ratio strongly correlated with CSF pTau-181 and total Tau (R = 0.80). GFR had minimal influence on plasma biomarker ratios. Plasma pTau-217 exhibited excellent AUC values (0.94-0.97) for distinguishing CSF A+/T+ and A+ status, showing higher discriminative accuracy than pTau-181 and Aβ42/Aβ40 (AUCs: 0.66-0.83). Optimal cutoff for plasma pTau-217 indicated excellent accuracy (93.3%), sensitivity (91.8%), and specificity (95.1%). AD-DEM patients displayed the highest pTau-217 levels, with significant differences across clinical groups.

Discussion: The findings confirm that Lumipulse plasma pTau-217 offers superior diagnostic accuracy for reflecting CSF A/T status. Plasma pTau-217 emerged as an accurate standalone biomarker of AD neuropathology across MCI and dementia stages. The study underscores the utility of automated Lumipulse assays, promoting their integration into routine diagnostic workflows to facilitate early and accurate AD detection.

Keywords: Alzheimer’s disease; Aβ42/Aβ40; Blood-based biomarkers; Diagnostic accuracy; Lumipulse; Plasma biomarkers; pTau-181; pTau-217.

PubMed Disclaimer

References

    1. Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14:535–562 - DOI - PubMed
    1. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629 - DOI - PubMed
    1. Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E et al (2024) Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol 81:255–263 - DOI - PubMed - PMC
    1. Bellomo G, Bayoumy S, Megaro A, Toja A, Nardi G, Gaetani L et al (2024) Fully automated measurement of plasma Abeta42/40 and p-tau181: analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts. Alzheimers Dement
    1. Jonaitis EM, Janelidze S, Cody KA, Langhough R, Du L, Chin NA et al (2023) Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease. Brain Commun 5:fcad057 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources